Literature DB >> 32733088

Loss of Caveolin-1 and caveolae leads to increased cardiac cell stiffness and functional decline of the adult zebrafish heart.

Dimitrios Grivas1,2, Álvaro González-Rajal1,3, Carlos Guerrero Rodríguez4, Ricardo Garcia4, José Luis de la Pompa5,6.   

Abstract

Caveolin-1 is the main structural protein of caveolae, small membrane invaginations involved in signal transduction and mechanoprotection. Here, we generated cav1-KO zebrafish lacking Cav1 and caveolae, and investigated the impact of this loss on adult heart function and response to cryoinjury. We found that cardiac function was impaired in adult cav1-KO fish, which showed a significantly decreased ejection fraction and heart rate. Using atomic force microscopy, we detected an increase in the stiffness of epicardial cells and cells of the cortical zone lacking Cav1/caveolae. This loss of cardiac elasticity might explain the decreased cardiac contraction and function. Surprisingly, cav1-KO mutants were able to regenerate their heart after a cryoinjury but showed a transient decrease in cardiomyocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32733088      PMCID: PMC7393500          DOI: 10.1038/s41598-020-68802-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  54 in total

1.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

2.  Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1.

Authors:  Hemal H Patel; Yasuo M Tsutsumi; Brian P Head; Ingrid R Niesman; Michelle Jennings; Yousuke Horikawa; Diane Huang; Ana L Moreno; Piyush M Patel; Paul A Insel; David M Roth
Journal:  FASEB J       Date:  2007-02-01       Impact factor: 5.191

3.  De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.

Authors:  A M Fra; E Williamson; K Simons; R G Parton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

4.  Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.

Authors:  Alex W Cohen; David S Park; Scott E Woodman; Terrence M Williams; Madhulika Chandra; Jamshid Shirani; Andrea Pereira de Souza; Richard N Kitsis; Robert G Russell; Louis M Weiss; Baiyu Tang; Linda A Jelicks; Stephen M Factor; Vitaliy Shtutin; Herbert B Tanowitz; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2002-10-09       Impact factor: 4.249

5.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

6.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

7.  Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.

Authors:  P E Scherer; R Y Lewis; D Volonte; J A Engelman; F Galbiati; J Couet; D S Kohtz; E van Donselaar; P Peters; M P Lisanti
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

8.  Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.

Authors:  Libin Liu; Dennis Brown; Mary McKee; Nathan K Lebrasseur; Dan Yang; Kenneth H Albrecht; Katya Ravid; Paul F Pilch
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

9.  Freeze-fracture replica immunolabelling reveals caveolin-1 in the human cardiomyocyte plasma membrane.

Authors:  Horst Robenek; Gabriele Weissen-Plenz; Nicholas J Severs
Journal:  J Cell Mol Med       Date:  2008-09-13       Impact factor: 5.310

10.  Caveolae protect endothelial cells from membrane rupture during increased cardiac output.

Authors:  Jade P X Cheng; Carolina Mendoza-Topaz; Gillian Howard; Jessica Chadwick; Elena Shvets; Andrew S Cowburn; Benjamin J Dunmore; Alexi Crosby; Nicholas W Morrell; Benjamin J Nichols
Journal:  J Cell Biol       Date:  2015-10-12       Impact factor: 10.539

View more
  5 in total

1.  Wt1 transcription factor impairs cardiomyocyte specification and drives a phenotypic switch from myocardium to epicardium.

Authors:  Ines J Marques; Alexander Ernst; Prateek Arora; Andrej Vianin; Tanja Hetke; Andrés Sanz-Morejón; Uta Naumann; Adolfo Odriozola; Xavier Langa; Laura Andrés-Delgado; Benoît Zuber; Carlos Torroja; Marco Osterwalder; Filipa C Simões; Christoph Englert; Nadia Mercader
Journal:  Development       Date:  2022-03-25       Impact factor: 6.868

2.  Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway.

Authors:  Kun Zhao; Jing Zhang; Tianhua Xu; Chuanxi Yang; Liqing Weng; Tingting Wu; Xiaoguang Wu; Jiaming Miao; Xiasheng Guo; Juan Tu; Dong Zhang; Bin Zhou; Wei Sun; Xiangqing Kong
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

Review 3.  Can't handle the stress? Mechanobiology and disease.

Authors:  Noam Zuela-Sopilniak; Jan Lammerding
Journal:  Trends Mol Med       Date:  2022-06-15       Impact factor: 15.272

Review 4.  Sensing and Responding of Cardiomyocytes to Changes of Tissue Stiffness in the Diseased Heart.

Authors:  Juliane Münch; Salim Abdelilah-Seyfried
Journal:  Front Cell Dev Biol       Date:  2021-02-26

5.  Atomic force microscopy identifies the alteration of rheological properties of the cardiac fibroblasts in idiopathic restrictive cardiomyopathy.

Authors:  Mizuki Matsumoto; Hirofumi Tsuru; Hidehiro Suginobe; Jun Narita; Ryo Ishii; Masaki Hirose; Kazuhisa Hashimoto; Renjie Wang; Chika Yoshihara; Atsuko Ueyama; Ryosuke Tanaka; Keiichi Ozono; Takaharu Okajima; Hidekazu Ishida
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.